<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-pharmaceuticals-12-00147">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Panozzo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>D.Y.</given-names>
   </name>
   <name>
    <surname>Margo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Morton</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Piedrafita</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mosse</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hurt</surname>
    <given-names>A.C.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>120</volume>
  <fpage>66</fpage>
  <lpage>71</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.05.007</pub-id>
  <?supplied-pmid 26022199?>
  <pub-id pub-id-type="pmid">26022199</pub-id>
 </element-citation>
</ref>
